{"id":"W2131110909","doi":"10.1186/1471-2407-12-305","title":"Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial","year":2012,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency; Cancer Care Ontario","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"SABR volatility model; Medicine; Radiation therapy; Randomized controlled trial; Clinical endpoint; Quality of life (healthcare); Oncology; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02718186,0.005574139,0.005876607,0.001394999,0.003364805,0.003154282,0.00390121,0.005880519,0.05240707],"category_scores_gemma":[0.01965209,0.00220753,0.003480077,0.002017002,0.003297148,0.002519489,0.002362049,0.008545445,0.01402652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005413569,"about_ca_system_score_gemma":0.01801048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002034302,"about_ca_topic_score_gemma":0.005302425,"domain_scores_codex":[0.9853809,0.009704038,0.0009767377,0.0011351,0.001558047,0.001245132],"domain_scores_gemma":[0.9899734,0.001536271,0.002422882,0.001412475,0.001738192,0.002916789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9200435,0.01335178,0.001008892,0.008608527,0.001213605,0.0002245921,0.0002579983,0.001567995,0.002726903,0.003027273,0.02538259,0.02258634],"study_design_scores_gemma":[0.9501169,0.01664565,0.001268502,0.0008886913,0.0003843462,0.00005739899,0.00004883381,0.0007722549,0.000531928,0.001060636,0.02817884,0.0000460267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.002907162,0.000359529,0.001224559,0.0004014447,0.0003478974,0.9916192,0.001676243,0.0001128984,0.001351117],"genre_scores_gemma":[0.003016965,0.0002252,0.002165071,0.0003930259,0.00007543399,0.9926437,0.0005547284,0.00001008773,0.0009158175],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.05240707,"threshold_uncertainty_score":0.1753191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2310737765766304,"score_gpt":0.4427291918940041,"score_spread":0.2116554153173737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}